Search Clinical Trials
600,453 trials
ID
Status
Phase
Title
Sponsor
NCT07791875
AI-Based Analysis of Port Catheter Tip PositionBagcilar Training and Research HospitalNot Yet Recruiting
NCT07791875Not Yet Recruiting
—
AI-Based Analysis of Port Catheter Tip PositionBagcilar Training and Res...
NCT07792655
Telerehabilitation for Post-Stroke Hand FunctionAmerican Heart AssociationRecruitingNot Applicable
NCT07792655Recruiting
Not Applicable
Telerehabilitation for Post-Stroke Hand FunctionAmerican Heart Associatio...
NCT07792967
Physical Activity Modifies Exercise ResponsivenessVA Office of Research and DevelopmentNot Yet RecruitingNot Applicable
NCT07792967Not Yet Recruiting
Not Applicable
Physical Activity Modifies Exercise ResponsivenessVA Office of Research and...
NCT07793721
Effects of Risk Presentation Format and Frequently Asked Questions on Breast Cancer Risk SkepticismNational Cancer Institute (NCI)Not Yet RecruitingNot Applicable
NCT07793721Not Yet Recruiting
Not Applicable
Effects of Risk Presentation Format and Frequently Asked Questions on Breast Can...National Cancer Institute...
NCT07792772
Arrhythmia Detection With MEMO Patch Plus in Patients With Acute Heart FailureAsan Medical CenterCompletedNot Applicable
NCT07792772Completed
Not Applicable
Arrhythmia Detection With MEMO Patch Plus in Patients With Acute Heart FailureAsan Medical Center
NCT07792434
Nociplastic Pain in Patients Diagnosed With Subacromial Pain Syndrome (SAPS)Vejle HospitalNot Yet Recruiting
NCT07792434Not Yet Recruiting
—
Nociplastic Pain in Patients Diagnosed With Subacromial Pain Syndrome (SAPS)Vejle Hospital
NCT07792252
REWIRE: Real-world Engagement With Interventional and Rejoyn EffectivenessOtsuka Pharmaceutical Co., Ltd.Not Yet Recruiting
NCT07792252Not Yet Recruiting
—
REWIRE: Real-world Engagement With Interventional and Rejoyn EffectivenessOtsuka Pharmaceutical Co....
NCT07793656
mRNA Therapy to Restore Lymphatic Flow in Secondary LymphedemaFlash TherapeuticsNot Yet RecruitingPhase 1
NCT07793656Not Yet Recruiting
Phase 1
mRNA Therapy to Restore Lymphatic Flow in Secondary LymphedemaFlash Therapeutics
NCT07792148
Adapting the ESTEEM Intervention to Improve Mental Health and PrEP Uptake Among Men at Risk of HIVNational Institute of Mental Health (NIMH)Not Yet RecruitingNot Applicable
NCT07792148Not Yet Recruiting
Not Applicable
Adapting the ESTEEM Intervention to Improve Mental Health and PrEP Uptake Among...National Institute of Men...
NCT07793526
Back on Track: Evaluation of an Occupational Reintegration Protocol for Employees With Musculoskeletal DisordersAmsterdam UMC, location VUmcRecruiting
NCT07793526Recruiting
—
Back on Track: Evaluation of an Occupational Reintegration Protocol for Employee...Amsterdam UMC, location V...
NCT07791511
Added-Sugars Warning Label PSAsUniversity of California, DavisNot Yet RecruitingNot Applicable
NCT07791511Not Yet Recruiting
Not Applicable
Added-Sugars Warning Label PSAsUniversity of California,...
NCT07792330
Asthma Lung Sounds With Wearable StethoscopeChildren's Hospital Los AngelesNot Yet RecruitingNot Applicable
NCT07792330Not Yet Recruiting
Not Applicable
Asthma Lung Sounds With Wearable StethoscopeChildren's Hospital Los A...
NCT07792447
Antioxidant Nutrition and Facial Exercise for Skin AgingUniversity of ZakhoNot Yet RecruitingNot Applicable
NCT07792447Not Yet Recruiting
Not Applicable
Antioxidant Nutrition and Facial Exercise for Skin AgingUniversity of Zakho
NCT07793149
Comparison of KIRA Hydrating Treatment and Jet Peel for Facial Skin HydrationFaculty of Pharmacy Novi SadCompletedNot Applicable
NCT07793149Completed
Not Applicable
Comparison of KIRA Hydrating Treatment and Jet Peel for Facial Skin HydrationFaculty of Pharmacy Novi...
NCT07792473
Oral Care Interventions in PEG-Fed Palliative Care PatientsUniversity of YalovaNot Yet RecruitingNot Applicable
NCT07792473Not Yet Recruiting
Not Applicable
Oral Care Interventions in PEG-Fed Palliative Care PatientsUniversity of Yalova
Result Breakdown
Not yet recruiting13 (65%)
Recruiting4 (20%)
Completed3 (15%)
not_applicable11 (55%)
Not Specified6 (30%)
Phase 12 (10%)
Phase 31 (5%)